EUVIMEDEUVIMED entdecken
Crossref

Rodent Models and How They Define Potential Human Benefit: A Translational Review for Angelman Syndrome

Kelly M Knee, Edwin J Weeber, Niki Armstrong, Rachel E Stoub, Nicole A Copping, Barbara J Bailus, Yong-Hui Jiang, Elizebeth M Berry-Kravis, Allyson Berent

DATA, ANALYSIS, REVIEWS, TECHNIQUES · 2026 · (1)

DOI: 10.65856/ffkj4964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DATA, ANALYSIS, REVIEWS, TECHNIQUES, 2026. Verfasst von Kelly M Knee und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• Description: UBE3A silencing in primates consolidates around birth, leaving paternal UBE3A protein robustly expressed throughout early embryonic development. This developmental timing supports a largely postnatal pathogenesis in Angelman syndrome (AS) and provides a rationale for therapeutic benefit beyond infancy. Here we review AS genetics and imprinting biology, compare human and model-organism developmental timelines, and synthesize lessons from numerous AS mouse models, while simultaneously highlighting both their value for defining molecular mechanisms, biodistribution, and pharmacology, and their limits for predicting complex human outcomes. We summarize therapeutic strategies under evaluation (gene replacement, paternal allele unsilencing via antisense oligonucleotides or genome/epigenome editing, and hematopoietic stem-cell–based approaches) and emerging human trial results. Across modalities, data support the potential for meaningful rescue when UBE3A is restored postnatally across all ages, underscoring persistent circuit plasticity and the need for inclusive, age-spanning clinical trials, including newborn to adult ages, guided by rigorous biomarkers and translational endpoints.

Zitieren

APA

Knee, K. M., Weeber, E. J., Armstrong, N., Stoub, R. E., Copping, N. A., Bailus, B. J., Jiang, Y., Berry-Kravis, E. M., & Berent, A. (2026). Rodent Models and How They Define Potential Human Benefit: A Translational Review for Angelman Syndrome. DATA, ANALYSIS, REVIEWS, TECHNIQUES. https://doi.org/10.65856/ffkj4964

Vancouver

Knee KM, Weeber EJ, Armstrong N, Stoub RE, Copping NA, Bailus BJ, et al. Rodent Models and How They Define Potential Human Benefit: A Translational Review for Angelman Syndrome. DATA, ANALYSIS, REVIEWS, TECHNIQUES. 2026. doi:10.65856/ffkj4964

BibTeX
@article{Knee2026,
  author = {Knee, Kelly M and Weeber, Edwin J and Armstrong, Niki and Stoub, Rachel E and Copping, Nicole A and Bailus, Barbara J and Jiang, Yong-Hui and Berry-Kravis, Elizebeth M and Berent, Allyson},
  title = {Rodent Models and How They Define Potential Human Benefit: A Translational Review for Angelman Syndrome},
  journal = {DATA, ANALYSIS, REVIEWS, TECHNIQUES},
  year = {2026},
  number = {1},
  doi = {10.65856/ffkj4964}
}
Kostenlos starten →